n-butylbenzenesulfonamide has been researched along with Prostatic Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baniahmad, A; Claessens, F; Matusch, R; Papaioannou, M; Roell, D; Schleich, S; Schubert, U; Tanner, T | 1 |
Baniahmad, A; Roell, D | 1 |
1 review(s) available for n-butylbenzenesulfonamide and Prostatic Neoplasms
Article | Year |
---|---|
The natural compounds atraric acid and N-butylbenzene-sulfonamide as antagonists of the human androgen receptor and inhibitors of prostate cancer cell growth.
Topics: Androgen Receptor Antagonists; Cell Line, Tumor; Humans; Hydroxybenzoates; Male; Molecular Structure; Plant Extracts; Prostatic Hyperplasia; Prostatic Neoplasms; Receptors, Androgen; Sulfonamides | 2011 |
1 other study(ies) available for n-butylbenzenesulfonamide and Prostatic Neoplasms
Article | Year |
---|---|
NBBS isolated from Pygeum africanum bark exhibits androgen antagonistic activity, inhibits AR nuclear translocation and prostate cancer cell growth.
Topics: Androgen Antagonists; Cell Line, Tumor; Cell Nucleus; Cell Proliferation; Humans; Ligands; Male; Phytotherapy; Plant Bark; Plant Extracts; Prostate-Specific Antigen; Prostatic Neoplasms; Protein Binding; Protein Structure, Tertiary; Protein Transport; Prunus africana; Receptors, Androgen; Receptors, Progesterone; Sulfonamides; Transcription, Genetic | 2010 |